| A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy (NCT05212935) | Federico II University | 2022-05-01 |
| Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV (NCT04875819) | Thomas Benfield | 2021-04-28 |
| Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe (NCT03547271) | Sanofi Pasteur, a Sanofi Company | 2018-12-14 |
| Safety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population. (NCT04236960) | Walvax Biotechnology Co., Ltd. | 2018-07-17 |
| Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children (NCT03476135) | Sanofi Pasteur, a Sanofi Company | 2018-02-27 |
| Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA. (NCT03378258) | Belfast Health and Social Care Trust | 2017-11-09 |
| Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers (NCT02955797) | Sanofi Pasteur, a Sanofi Company | 2017-02-24 |
| Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years (NCT03077438) | Sanofi Pasteur, a Sanofi Company | 2017-02-17 |
| Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age (NCT02919293) | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 2016-08-01 |
| Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea (NCT02864927) | Sanofi Pasteur, a Sanofi Company | 2016-07-21 |
| Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine (NCT02842853) | Sanofi Pasteur, a Sanofi Company | 2016-07-15 |
| Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older (NCT02842866) | Sanofi Pasteur, a Sanofi Company | 2016-07-15 |
| Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam (NCT02640404) | Sanofi Pasteur, a Sanofi Company | 2016-06-06 |
| Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine (NCT02752906) | Sanofi Pasteur, a Sanofi Company | 2016-04-15 |
| The Long-term Impact of Invasive Meningococcal Disease in Australian Adolescents and Young Adults (NCT03798574) | University of Adelaide | 2016-03-01 |
| Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian Federation (NCT02699840) | Sanofi Pasteur, a Sanofi Company | 2016-02-01 |
| Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years Earlier (NCT02633787) | Sanofi Pasteur, a Sanofi Company | 2015-12-01 |
| Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects (NCT02591290) | Sanofi Pasteur, a Sanofi Company | 2015-10-20 |
| Investigating Meningococcal Vaccines in Adults (NCT02398396) | University of Oxford | 2015-04-01 |
| Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers (NCT03205358) | Sanofi Pasteur, a Sanofi Company | 2015-03-31 |
| Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba) (NCT02569632) | UCSF Benioff Children's Hospital Oakland | 2015-01-01 |
| Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents (NCT02199691) | Sanofi Pasteur, a Sanofi Company | 2014-07-22 |
| Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (NCT01897402) | JN-International Medical Corporation | 2013-07-01 |
| Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older (NCT01732627) | Sanofi Pasteur, a Sanofi Company | 2012-11-12 |
| Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis (NCT02041663) | Assistance Publique - Hôpitaux de Paris | 2012-03-05 |
| Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects (NCT01519713) | Sanofi Pasteur, a Sanofi Company | 2012-01-01 |
| Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis (NCT01482052) | JN-International Medical Corporation | 2011-11-01 |
| Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination (NCT01239043) | Sanofi | 2010-11-01 |
| Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine (NCT00862277) | Sanofi Pasteur, a Sanofi Company | 2008-12-01 |
| Bexsero™and Routine Infant Vaccines: Effect of Coadministration on the Safety of Immunization (NCT02712177) | CHU de Quebec-Universite Laval | 2008-08-01 |
| Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules (NCT00721396) | Novartis Vaccines | 2008-08-01 |
| Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children (NCT00616421) | Novartis Vaccines | 2008-03-01 |
| Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life (NCT00625677) | Public Health England | 2008-02-01 |
| Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers (NCT00626327) | Novartis Vaccines | 2008-02-01 |
| Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years (NCT00874549) | Sanofi Pasteur, a Sanofi Company | 2007-10-01 |
| A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults (NCT00474487) | Novartis Vaccines | 2007-05-01 |
| A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults (NCT00450437) | Novartis Vaccines | 2007-03-01 |
| Immunogenicity and Safety of Menactra® Vaccine in Adolescents in Saudi Arabia (NCT00444951) | Sanofi Pasteur, a Sanofi Company | 2007-02-01 |
| Creation of a Biotheque of Patients of Seine-Maritime With Meningococcal Infection (NCT00450632) | University Hospital, Rouen | 2005-09-01 |
| Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines (NCT00197808) | Public Health England | 2005-04-01 |
| Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune® (NCT00850603) | Sanofi Pasteur, a Sanofi Company | 2002-10-01 |